Diversified Enterprises’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Diversified Enterprises's BMY Position: Q2 2026 in Review
Diversified Enterprises increased its Bristol-Myers Squibb (BMY) stake by 41% in Q2 2026, buying an estimated $279K and bringing the position to 16,834 shares worth $970K. The position accounts for 0.05% of the portfolio, ranked #167.
Diversified Enterprises first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Diversified Enterprises held 16,834 shares of Bristol-Myers Squibb worth $970K as of Q2 2026.
- Diversified Enterprises bought 4,867 Bristol-Myers Squibb shares in Q2 2026, an estimated $279K.
- Bristol-Myers Squibb made up 0.05% of Diversified Enterprises's portfolio in Q2 2026, its #167 holding.
- Diversified Enterprises first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.